Clinical Trials Sponsored by Array Genomics

Total 509 results

Transplant Genomics, Inc.

Not yet recruiting

CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients (CLARITY)

Kidney Transplant Rejection
Transplant Genomics, Inc.

Not yet recruiting

TRU-IMMUNO: Optimizing Liver Immunosuppression

Liver Transplant Rejection
Cofactor Genomics, Inc.

Recruiting

Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer (PREDAPT-HNSCC2)

Head and Neck Squamous Cell Carcinoma

United States
Bluestar Genomics Inc.

Recruiting

New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) (NODMED)

Pancreatic Cancer

United States
Transplant Genomics, Inc.

Recruiting

TruGraf® Long-term Clinical Outcomes Study

Kidney Transplant Rejection

United States
Quantum Genomics SA

Completed

Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction (QUORUM)

Myocardial Infarction

Poland, Germany, France, Hungary, Slovakia, Spain, United Kingdom
Clinical Genomics Pathology

Completed

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL (PASCAL)

Colorectal Cancer

United States
Quantum Genomics SA

Terminated

QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF (QUID-HF)

Heart Failure

France, Germany, Netherlands, United Kingdom, Hungary, Norway, Czechia, Poland
Everist Genomics, Inc

Completed

Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study

Cardiovascular Diseases

Canada
Everist Genomics, Inc

Completed

AngioDefender Versus Brachial Artery Ultrasound Imaging

Cardiovascular Diseases

United States, Canada
Everist Genomics, Inc

Completed

Brachial Artery Ultrasound Imaging: A Repeatability Study

Cardiovascular Diseases

United States
Quantum Genomics SA

Completed

Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects

Essential Hypertension

France
American Genomics, LLC

Completed

A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population

Anesthesia, Local

United States
Convergent Genomics, Inc.

Completed

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX ) (CGI-EPM-IX)

SARS-CoV-2

United States
American Genomics, LLC

Completed

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Anesthesia, Local

United States
Shanghai Genomics, Inc.

Completed

A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis (HBV)

Hepatitis B, Chronic

China
American Genomics, LLC

Completed

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Anesthesia, Local

United States
American Genomics, LLC

Completed

An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920

Healthy

United States
Clinical Genomics Pathology

Completed

Colvera for Detection of Disease Recurrence (NOVA)

Colorectal Adenocarcinoma

United States
Quantum Genomics SA

Completed

Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins (NEW-HOPE)

Hypertension

United States
Quantum Genomics SA

Completed

Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo

Essential Hypertension

France
Sirius Genomics Inc.

Unknown

Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis

Septic Shock | Severe Sepsis

United States, Canada, France, United Kingdom
Żelazna Medical Centre, LLC
Laboratory of Genetics and Human Genomics, University of Gdańsk

Completed

Genetic Aspects of Vaginal Aging

Genitourinary Agents

Poland
Massachusetts General Hospital
Pfizer; Array BioPharma

Recruiting

Lorlatinib Combinations in Lung Cancer

NSCLC | Lung Cancer | Relapsed Cancer | Resistant Cancer | MET Amplification | Anaplastic Lymphoma Kinase Gene Translocation | ROS1 Rearrangement

United States
M.D. Anderson Cancer Center
Array BioPharma

Terminated

An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)

Leukemia

United States
Centre Hospitalier Arras

Completed

Relieve the Patient's Thirst, Refresh the Mouth First (ICU-MIC) (ICU-MIC)

Dehydration | Hypernatremia

France
Razor Genomics
Encore Clinical

Recruiting

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States, France, Germany
Global Genomics Group, LLC

Unknown

GLOBAL Clinical Study (GLOBAL)

Coronary Artery Disease

United Kingdom, United States, Hungary, Netherlands, Australia, Germany, Poland, Canada, Croatia
Merck Sharp & Dohme LLC
Array BioPharma

Completed

Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651)

Metastatic Colorectal Cancer

United States, Canada
PETHEMA Foundation
Celgene Corporation; Array BioPharma

Completed

Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients

Multiple Myeloma

Spain
M.D. Anderson Cancer Center
Array BioPharma

Terminated

MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy

Leukemia

United States
Centre Hospitalier Arras

Completed

Under the Nose Face Mask to Prevent Facial Pressure Ulcers During NIV for Acute Hypercapnic Respiratory Failure (AHRF) (UNDER PRESSURE)

Acute Hypercapnic Respiratory Failure

France
Centre Hospitalier Arras

Completed

Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context (RECOVERY)

COVID-19 | Obesity

France
Centre Hospitalier Arras

Completed

Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICU (VPP-ImPRoVE)

Acute Circulatory Failure

France
Centre Hospitalier Arras

Completed

Severe Obesity and Eating Habits (OSCAR) (OSCAR)

Eating Disorders | Severe Obesity

France
Dana-Farber Cancer Institute
Pfizer; Array BioPharma

Active, not recruiting

Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
Array BioPharma

Completed

A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Advanced BRAF Mutant Cancers

United States
University of California, San Francisco
Array BioPharma

Recruiting

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Melanoma Stage IV | Melanoma Stage III

United States
Transplant Genomics, Inc.
Duke University

Terminated

Acceptability and Feasibility of TruGraf® Testing as Part of the Standard of Care

Kidney Transplant Rejection

United States
Quantum Genomics SA
Eurofins Optimed

Completed

Pharmacokinetics in End Stage Renal Disease Patients

Renal Failure | Healthy Volunteers

France
Genomic Prediction Inc.

Active, not recruiting

ANXA5 M2 Haplotyping in IVF Patients and Embryos

Infertility | Pregnancy Complications | Miscarriage, Recurrent

United States
Genomic Prediction Inc.

Active, not recruiting

Embryo Health Study (EHS)

Infertility | Hereditary Diseases

United States
Singlera Genomics Inc.
Fudan University

Recruiting

The FuSion Program: A Prospective and Multicenter Cohort Study of Pan-Cancer Screening in Chinese Population

Cancer

China
Northwestern University
Transplant Genomics, Inc.

Recruiting

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients (Mini-Kidney)

Acute Rejection (AR) of Transplanted Kidney | Chronic Allograft Nephropathy (CAN) | Interstitial Fibrosis (IF) | Tubular Atrophy (TA)

United States
Transplant Genomics, Inc.
Scripps Health

Enrolling by invitation

Molecular Biomarkers in Renal Transplantation Via TruGraf® Test

Kidney Transplant Rejection

United States
Massachusetts General Hospital
Clinical Genomics

Withdrawn

A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer

Gastrointestinal Malignancies

United States
Memorial Sloan Kettering Cancer Center
Array BioPharma

Completed

BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation

Melanoma

United States
Memorial Sloan Kettering Cancer Center
Array BioPharma

Completed

First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma

Advanced Biliary Tract Carcinoma

United States
Genomic Prediction Inc.

Recruiting

Preimplantation Genetic Testing in Women of Advanced Maternal Age (GETSET)

Infertility, Female

United States
Cofactor Genomics, Inc.
Curebase Inc.

Recruiting

A Multicenter Cancer Biospecimen Collection Study

Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Triple Negative Breast Cancer | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Cancer of Head and Neck | Lung Cancer, Nonsmall Cell | Gastroesophageal Junction Adenocarcinoma

United States

Clinical Trials Sponsored by Array Genomics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations